Cochrane Abstracts
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mesenchymal Stromal Cells as Treatment or Prophylaxis for Acute or Chronic Graft‐versus‐host Disease in Haematopoietic Stem Cell Transplant (HSCT) Recipients With a Haematological Condition." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/Mesenchymal_stromal_cells_as_treatment_or_prophylaxis_for_acute_or_chronic_graft‐versus‐host_disease_in_haematopoietic_stem_cell_transplant__HSCT__recipients_with_a_haematological_condition.
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/Mesenchymal_stromal_cells_as_treatment_or_prophylaxis_for_acute_or_chronic_graft‐versus‐host_disease_in_haematopoietic_stem_cell_transplant__HSCT__recipients_with_a_haematological_condition. Accessed December 2, 2024.
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/Mesenchymal_stromal_cells_as_treatment_or_prophylaxis_for_acute_or_chronic_graft‐versus‐host_disease_in_haematopoietic_stem_cell_transplant__HSCT__recipients_with_a_haematological_condition
Mesenchymal Stromal Cells as Treatment or Prophylaxis for Acute or Chronic Graft‐versus‐host Disease in Haematopoietic Stem Cell Transplant (HSCT) Recipients With a Haematological Condition [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/Mesenchymal_stromal_cells_as_treatment_or_prophylaxis_for_acute_or_chronic_graft‐versus‐host_disease_in_haematopoietic_stem_cell_transplant__HSCT__recipients_with_a_haematological_condition.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition
ID - 432099
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/Mesenchymal_stromal_cells_as_treatment_or_prophylaxis_for_acute_or_chronic_graft‐versus‐host_disease_in_haematopoietic_stem_cell_transplant__HSCT__recipients_with_a_haematological_condition
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
